Focal Biosciences AG
Focal Biosciences AG develops AI-driven chromatin reprogramming technologies to reverse and cure chronic diseases.
About
Focal Biosciences AG is a biotechnology company based in Switzerland, focused on revolutionizing disease treatment by reprogramming cells to healthier states through chromatin fingerprint technologies. Their AI-enhanced CFC (Chromatin Fingerprint for Cell state)-Platform enables rapid and broad reprogramming of cells, aiming to deliver disease-modifying and potentially curative medicines for chronic and age-related diseases such as fibrosis, senescence, aging, and cancer. The company strives to redefine drug discovery by leveraging tissue-mimicking disease models and advanced machine learning to target the root causes of diseases at the chromatin level.
Products & Services
- CFC (Chromatin Fingerprint for Cell state)-Platform for cell reprogramming
- AI-driven drug discovery pipeline
- Tissue-mimicking disease models
Use Cases & Case Studies
-
Partnerships & Collaborations
-
Awards & Recognition
-
Contact Information
Certifications & Compliance
- GDPR compliance (as applicable in Switzerland)